Purpose In heart failure with reduced ejection fraction (HFrEF), the effects of automatic
positive airway pressure therapy (APAP) for obstructive sleep apnea (OSA) on sleep quality …

Background Moderate-to-severe obstructive sleep apnea (OSA) has been documented in
about 20% of patients with heart failure and reduced ejection fraction (HF-REF). Continuous …

Background: The aim of the study was to study the effect of 6 months of continuous positive
airway pressure (CPAP) in community heart failure (HF) patients with obstructive sleep …

Background Comorbidity of obstructive sleep apnea (OSA) and heart failure (HF) is
becoming increasingly common. This is a global analysis of positive airway pressure (PAP) …

Aims Obstructive sleep apnoea (OSA) is highly prevalent in patients with chronic heart
failure (CHF) and may contribute to CHF progression. We aimed to determine whether …

BACKGROUND AND PURPOSE: Continuous positive airway pressure (CPAP) is an
effective treatment for sleep apnea (SA), although the evidence for improving chronic heart …

Patients with heart failure or OSA (obstructive sleep apnoea) have reduced HF-HRV (high-
frequency heart rate variability), indicating reduced cardiac vagal modulation, a marker of …

Background Moderate-to-severe obstructive sleep apnea (OSA) is highly prevalent in heart
failure patients with reduced left ventricular ejection fraction (HFrEF), and is associated with …

Introduction Obstructive sleep apnoea (OSA) as well as central sleep apnoea (CSA) are
highly prevalent in heart failure (HF) patients. Positive airway pressure (PAP) therapy is …

Background Obstructive sleep apnea (OSA) is prevalent in patients with heart failure.
Treatment with continuous positive airway pressure (CPAP) improves systolic function in …